Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage

Neurocritical Care

Volumn 8, Issue 3, 2008, Pages 418-426

  Chwajol, Mark ^a   Starke, Robert M ^b   Kim, Grace H ^b   Mayer, Stephan A ^b   Connolly, E Sander ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

Aminocaproic acid; Aneurysm; Antifibrinolytics; Rebleeding; Subarachnoid hemorrhage

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; NICARDIPINE; NIMODIPINE; TRANEXAMIC ACID;

ACUTE KIDNEY THROMBOSIS; ANEURYSM; BLEEDING; BRAIN ISCHEMIA; BRAIN VASCULITIS; BRAIN VASOSPASM; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MEGADOSE; DRUG WITHDRAWAL; HEART INFARCTION; HUMAN; HYDROCEPHALUS; KIDNEY DISEASE; KIDNEY FAILURE; LOADING DRUG DOSE; LONG TERM CARE; LUNG EMBOLISM; MAXIMUM PLASMA CONCENTRATION; MORTALITY; MYOPATHY; OUTCOME ASSESSMENT; PATIENT MONITORING; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REBLEEDING; REVIEW; RHABDOMYOLYSIS; SHORT COURSE THERAPY; STROKE; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ANTIFIBRINOLYTIC AGENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SUBARACHNOID HEMORRHAGE;

EID: 51449117262     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-008-9088-5     Document Type: Review

References (86)

1. JW Hop GJ Rinkel A Algra J van Gijn 1998 Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage Stroke 29 798 804
2. AH Ropper NT Zervas 1984 Outcome 1 year after sah from cerebral aneurysm. Management morbidity, mortality, and functional status in 112 consecutive good-risk patients J Neurosurg 60 909 15
3. JD Laidlaw KH Siu 2002 Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age J Neurosurg 97 250 8 discussion 247-59
4. JA Jane NF Kassell JC Torner HR Winn 1985 The natural history of aneurysms and arteriovenous malformations J Neurosurg 62 321 3
5. NF Kassell JC Torner 1983 Aneurysmal rebleeding: a preliminary report from the cooperative aneurysm study Neurosurgery 13 479 81
6. NF Kassell JC Torner EC Haley Jr JA Jane HP Adams GL Kongable 1990 The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results J Neurosurg 73 18 36
7. Y Fujii S Takeuchi O Sasaki T Minakawa T Koike R Tanaka 1996 Ultra-early rebleeding in spontaneous subarachnoid hemorrhage J Neurosurg 84 35 42
8. J Hillman S Fridriksson O Nilsson Z Yu H Saveland KE Jakobsson 2002 Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study J Neurosurg 97 771 8
9. T Inagawa K Kamiya H Ogasawara T Yano 1987 Rebleeding of ruptured intracranial aneurysms in the acute stage Surg Neurol 28 93 9
10. J Rosenorn V Eskesen K Schmidt F Ronde 1987 The risk of rebleeding from ruptured intracranial aneurysms J Neurosurg 67 329 32
11. HP Adams Jr DW Nibbelink JC Torner AL Sahs 1981 Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study Arch Neurol 38 25 9
12. AA Ameen R Illingworth 1981 Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm J Neurol, Neurosurg Psychiatry 44 220 6
13. A Hijdra J van Gijn NJ Nagelkerke M Vermeulen H van Crevel 1988 Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage Stroke 19 1250 6
14. NF Kassell JC Torner HP Adams Jr 1984 Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the cooperative aneurysm study J Neurosurg 61 225 30
15. DW Nibbelink JC Torner WG Henderson 1975 Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage Stroke 6 622 9
16. G Pinna A Pasqualin C Vivenza R Da Pian 1988 Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study Acta Neurochir 93 77 87
17. G Schisano 1978 The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage Surg Neurol 10 217 22
18. D Tovi 1973 The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage Acta Neurol Scand 49 163 75
19. TJ Leipzig K Redelman TG Horner 1997 Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy J Neurosurg 86 220 5
20. Y Roos 2000 Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. Star study group Neurology 54 77 82
21. YB Roos GJ Rinkel M Vermeulen A Algra J van Gijn 2005 Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev (Online) 1 CD000277
22. KJ Burchiel JM Hoffman RA Bakay 1984 Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition Neurosurgery 14 57 63
23. KJ Burchiel G Schmer 1981 A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms J Neurosurg 54 12 5
24. H Fodstad IM Nilsson 1981 Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (amca) Acta Neurochir 56 25 38
25. H Fodstad A Pilbrant M Schannong S Stromberg 1981 Determination of tranexamic acid (amca) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage Acta Neurochir 58 1 13
26. DW Beck HP Adams ES Flamm JC Godersky CM Loftus 1988 Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage Stroke 19 63 7
27. KC Petruk M West G Mohr BK Weir BG Benoit F Gentili LB Disney MI Khan M Grace RO Holness 1988 Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial J Neurosurg 68 505 17
28. G Stroobandt O Lambert E Menard 1998 The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms Acta Neurochir 140 148 60
29. R Geronemus DA Herz K Shulman 1974 Streptokinase clot lysis time in patients with ruptured intracranial aneurysms J Neurosurg 40 499 503
30. R Sawaya V Sonnino RL McLaurin G Perrotta 1983 Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of csf fibrin/fibrinogen degradation products J Neurosurg 58 699 707
31. JM Porter AJ Acinapura JP Kapp D Silver 1966 Fibrinolytic activity of the spinal fluid and meninges Surg Forum 17 425 7
32. BJ Levy D Silver 1968 Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity Surg Forum 19 413 4
33. H Fodstad A Forssell B Liliequist M Schannong 1981 Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial Neurosurgery 8 158 65
34. D Tovi IM Nilsson CA Thulin 1972 Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study Acta Neurol Scand 48 393 402
35. RR Smith JJ Upchurch 1973 Monitoring antifibrinolytic therapy in subarachnoid hemorrhage J Neurosurg 38 339 44
36. D Tovi IM Nilsson CA Thulin 1973 Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage Acta Neurol Scand 49 1 9
37. RS Maurice-Williams 1978 Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J 1 945 7
38. AH Uttley M Buckell 1968 Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage J Neurol Neurosurg Psychiatry 31 621 7
39. M Vermeulen HH van Vliet KW Lindsay A Hijdra J van Gijn 1985 Source of fibrin/fibrinogen degradation products in the csf after subarachnoid hemorrhage J Neurosurg 63 573 7
40. DW Nibbelink 1971 Antifibrinolytic activity during administration of epsilon-aminocaproic acid Stroke 2 555 8
41. HP Adams Jr NF Kassell JC Torner DW Nibbelink AL Sahs 1981 Early management of aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study J Neurosurg 54 141 5
42. FH Vermeij D Hasan HW Bijvoet CJ Avezaat 1998 Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage Stroke 29 924 30
43. Starke RM, Kim GH, Fernandez A, Hickman ZL, Ducruet AF, Kellner CP, Hahn DK, Chwajol M, Komotar RJ, Otten M, Mayer SA, Connolly ES. Impact of a policy of early antifibrinolytic therapy for the prevention of acute rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(9).
44. B Chandra 1978 Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial Ann Neurol 3 502 4
45. M Kaste M Ramsay 1979 Tranexamic acid in subarachnoid hemorrhage. A double-blind study Stroke 10 519 22
46. SA Tsementzis ER Hitchcock CH Meyer 1990 Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study Acta Neurochir 102 1 10
47. J van Rossum AR Wintzen LJ Endtz JH Schoen H de Jonge 1977 Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial Ann Neurol 2 238 42
48. M Vermeulen KW Lindsay GD Murray F Cheah A Hijdra JP Muizelaar M Schannong GM Teasdale H van Crevel J van Gijn 1984 Antifibrinolytic treatment in subarachnoid hemorrhage N Engl J Med 311 432 7
49. JP Girvin 1973 The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms Trans Am Neurol Assoc 98 150 2
50. J Hillman C von Essen W Leszniewski I Johansson 1988 Significance of "ultra-early" rebleeding in subarachnoid hemorrhage J Neurosurg 68 901 7
51. YB Roos LF Beenen RJ Groen KW Albrecht M Vermeulen 1997 Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery J Neurol Neurosurg Psychiatry 63 490 3
52. H Ohkuma H Tsurutani S Suzuki 2001 Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management Stroke 32 1176 80
53. UM Chowdhary K Sayed 1981 Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage J Neurol Neurosurg Psychiatry 44 810 3
54. B Guidetti A Spallone 1981 The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms Surg Neurol 15 239 48
55. NR Graff-Radford J Torner HP Adams Jr NF Kassell 1989 Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the cooperative aneurysm study Arch Neurol 46 744 52
56. JA Kenning RC Heros M Dujovny RE Latchaw D Nelson 1984 An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid- hemorrhagic cerebral vasospasm and hydrocephalus Surg Neurol 21 159 64
57. M Knibestol A Karadayi D Tovi 1976 Echo-encephalographic study of ventricular dilatation after subarachnoid hemorrhage, with special reference to the effect of antifibrinolytic treatment Acta Neurol Scand 54 57 70
58. BE Park 1979 Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor Surg Neurol 11 73 80
59. SA Tsementzis WP Honan S Nightingale ER Hitchcock CH Meyer 1990 Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid Acta Neurochir 103 116 21
60. ES Flamm HP Adams Jr DW Beck RS Pinto JR Marler MD Walker JC Godersky CM Loftus J Biller DJ Boarini 1988 Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 68 393 400
61. JC Torner NF Kassell RB Wallace HP Adams Jr 1981 Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the cooperative aneurysm study Neurosurgery 9 506 13
62. HR Gralnick P Greipp 1971 Thrombosis with epsilon aminocaproic acid therapy Am J Clin Pathol 56 151 4
63. RL Naeye 1962 Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocapproic acid Blood 19 694 701
64. KS Woo LK Tse JL Woo J Vallance-Owen 1989 Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy Br J Clin Pract 43 465 6
65. HJ Gelmers 1980 Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid Acta Neurochir 52 45 50
66. RP Sengupta SC So FJ Villarejo-Ortega 1976 Use of epsilon aminocaproic acid (eaca) in the preoperative management of ruptured intracranial aneurysms J Neurosurg 44 479 84
67. H Fodstad B Liliequist M Schannong CA Thulin 1978 Tranexamic acid in the preoperative management of ruptured intracranial aneurysms Surg Neurol 10 9 15
68. S Pakarinen 1967 Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage. A study based on 589 cases diagnosed in a defined urban population during a defined period Acta Neurol Scand 43 Suppl 29 21 8
69. C Charytan D Purtilo 1969 Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy N Engl J Med 280 1102 4
70. RR Tubbs SP Benjamin DE Dohn 1979 Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report J Neurosurg 51 94 7
71. EP Hoffman AH Koo 1979 Cerebral thrombosis associated with amicar therapy Radiology 131 687 9
72. E Rydin PO Lundberg 1976 Letter: tranexamic acid and intracranial thrombosis Lancet 2 49
73. VK Sonntag BM Stein 1974 Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid J Neurosurg 40 480 5
74. RM Scott E Garrido 1977 Spontaneous thrombosis of an intracranial aneurysm during treatment with epsilon aminocaproic acid Surgical Neurol 7 21 3
75. JR Bennett 1972 Myopathy from e-aminocaproic acid: a second case Postgrad Med J 48 440 2
76. CK Biswas DA Milligan SD Agte DH Kenward PJ Tilley 1980 Acute renal failure and myopathy after treatment with aminocaproic acid Br Med J 281 115 6
77. CW Britt Jr RR Light BH Peters SS Schochet Jr 1980 Rhabdomyolysis during treatment with epsilon-aminocaproic acid Arch Neurol 37 187 8
78. HM Brodkin 1980 Myoglobinuria following epsilon-aminocaproic acid (eaca) therapy. Case report J Neurosurg 53 690 2
79. JA Brown RL Wollmann S Mullan 1982 Myopathy induced by epsilon-aminocaproic acid. Case report J Neurosurg 57 130 4
80. G Galassi M Gibertoni L Corradini A Colombo 1983 Why may epsilon-aminocaproic acid (eaca) induce myopathy in man? Report of a case and literature review Ital J Neurol Sci 4 489 92
81. C Kennard M Swash RA Henson 1980 Myopathy due to epsilon amino-caproic acid Muscle Nerve 3 202 6
82. RJ Lane NJ McLelland AM Martin FL Mastaglia 1979 Epsilon aminocaproic acid (eaca) myopathy Postgrad Med J 55 282 5
83. AR MacKay UH Sang PR Weinstein 1978 Myopathy associated with epsilon-aminocaproic acid (eaca) therapy. Report of two cases J Neurosurg 49 597 601
84. JA Vanneste GK van Wijngaarden 1982 Epsilon-aminocaproic acid myopathy. Report of a case and literature review Eur Neurol 21 242 8
85. R Glick D Green C Ts'ao WA Witt AT Yu AJ Raimondi 1981 High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage Neurosurgery 9 398 401
86. AJ Wysenbeek A Sella I Blum D Yeshurun 1979 Acute delirious state after epsilon-amino caproic acid administration Clin Toxicol 14 93 5